BC
BIT Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+55.19%
1 Year Return
+78.29%
3 Year Return
+538.68%
5 Year Return
+1,918.1%
10 Year Return
–
AUM
$1.53B
AUM Growth
+$1.53B
(+85%)
Cap. Flow
+$275M
Cap. Flow
% of AUM
17.89%
Top 10 Holdings %
Top 10 Hldgs %
62.04%
Holding
107
New
16
Increased
32
Reduced
30
Closed
21
Top Buys
| 1 |
NVIDIA
NVDA
|
$103M |
| 2 |
SoFi Technologies
SOFI
|
$66.6M |
| 3 |
TSMC
TSM
|
$59.9M |
| 4 |
Amazon
AMZN
|
$47.8M |
| 5 |
Advanced Micro Devices
AMD
|
$43.7M |
Top Sells
| 1 |
Oscar Health
OSCR
|
$76.3M |
| 2 |
Duolingo
DUOL
|
$50.2M |
| 3 |
Grindr
GRND
|
$44.8M |
| 4 |
BridgeBio Pharma
BBIO
|
$23.3M |
| 5 |
Robinhood
HOOD
|
$20.7M |
Sector Composition
| 1 | Financials | 39.09% |
| 2 | Technology | 32.72% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Healthcare | 5.58% |
| 5 | Communication Services | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
BridgeBio Pharma
BBIO
$9.91B
| $758K | 0.04% |
17,560
-540,086
| -97% | -$23.3M |
|
52
Uber
UBER
$194B
| $678K | 0.04% |
7,264
+3,205
| +79% | +$299K |
|
53
Airbnb
ABNB
$76.5B
| $562K | 0.03% |
4,247
+415
| +11% | +$54.9K |
|
54
Alibaba
BABA
$325B
| $539K | 0.03% |
+4,750
| New | +$539K |
|
55
Zoom
ZM
$25B
| $485K | 0.03% |
+6,219
| New | +$485K |
|
56
Nu Holdings
NU
$72B
| $463K | 0.03% |
33,740
+942
| +3% | +$12.9K |
|
57
Applied Materials
AMAT
$124B
| $418K | 0.02% |
2,282
-338
| -13% | -$61.9K |
|
58
Intuitive Surgical
ISRG
$158B
| $408K | 0.02% |
750
+421
| +128% | +$229K |
|
59
Braze
BRZE
$2.85B
| $382K | 0.02% |
+13,595
| New | +$382K |
|
60
UnitedHealth
UNH
$279B
| $367K | 0.02% |
1,177
+318
| +37% | +$99.2K |
|
61
EVgo
EVGO
$515M
| $360K | 0.02% |
98,660
+76,344
| +342% | +$279K |
|
|
GTM
62
ZoomInfo Technologies
GTM
$3.31B
| $290K | 0.02% |
28,668
+2,005
| +8% | +$20.3K |
|
|
BPMC
63
DELISTED
Blueprint Medicines
BPMC
| $182K | 0.01% |
1,423
-76,379
| -98% | -$9.79M |
|
64
Scholar Rock
SRRK
$3.3B
| $152K | 0.01% |
4,278
-38,416
| -90% | -$1.36M |
|
65
IDEAYA Biosciences
IDYA
$2.26B
| $88.7K | 0.01% |
4,220
-38,495
| -90% | -$809K |
|
66
argenx
ARGX
$44.2B
| $87.1K | 0.01% |
158
-1,689
| -91% | -$931K |
|
67
Ultragenyx Pharmaceutical
RARE
$3.04B
| $74.7K | ﹤0.01% |
2,055
-19,600
| -91% | -$713K |
|
68
Agios Pharmaceuticals
AGIO
$2.36B
| $74.2K | ﹤0.01% |
2,230
-19,238
| -90% | -$640K |
|
69
Revolution Medicines
RVMD
$7.43B
| $71.9K | ﹤0.01% |
1,955
-3,089
| -61% | -$114K |
|
70
Immunocore
IMCR
$1.78B
| $68.3K | ﹤0.01% |
2,176
-38,611
| -95% | -$1.21M |
|
71
Akero Therapeutics
AKRO
$3.65B
| $67.3K | ﹤0.01% |
1,261
-3,176
| -72% | -$169K |
|
72
Enliven Therapeutics
ELVN
$1.24B
| $63.8K | ﹤0.01% |
3,181
-16,205
| -84% | -$325K |
|
73
Beam Therapeutics
BEAM
$1.9B
| $61.3K | ﹤0.01% |
3,603
-12,168
| -77% | -$207K |
|
74
AnaptysBio
ANAB
$630M
| $60.1K | ﹤0.01% |
2,706
-22,716
| -89% | -$504K |
|
75
Day One Biopharmaceuticals
DAWN
$766M
| $54.7K | ﹤0.01% |
8,413
-108,152
| -93% | -$703K |
|